GDF10 inhibits cell proliferation and epithelial–mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways
Abstract Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the mole...
Saved in:
Published in | Carcinogenesis (New York) Vol. 43; no. 2; pp. 94 - 103 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
UK
Oxford University Press
24.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2′-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC.
Graphical Abstract
Graphical Abstract |
---|---|
AbstractList | Abstract
Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2′-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC.
Graphical Abstract
Graphical Abstract Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2′-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC. Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2'-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC.Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2'-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC. |
Author | Huang, Guangwu Midorikawa, Kaoru Kobayashi, Hatasu Oikawa, Shinji Takeuchi, Kazuhiko Ma, Ning Feng, Guofei He, Feng Zhang, Zhe Murata, Mariko |
Author_xml | – sequence: 1 givenname: Feng surname: He fullname: He, Feng organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan – sequence: 2 givenname: Guofei surname: Feng fullname: Feng, Guofei organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan – sequence: 3 givenname: Ning surname: Ma fullname: Ma, Ning organization: Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan – sequence: 4 givenname: Kaoru surname: Midorikawa fullname: Midorikawa, Kaoru organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan – sequence: 5 givenname: Shinji surname: Oikawa fullname: Oikawa, Shinji organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan – sequence: 6 givenname: Hatasu surname: Kobayashi fullname: Kobayashi, Hatasu organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan – sequence: 7 givenname: Zhe surname: Zhang fullname: Zhang, Zhe organization: Department of Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China – sequence: 8 givenname: Guangwu orcidid: 0000-0002-7376-5691 surname: Huang fullname: Huang, Guangwu organization: Key Laboratory of High-Incidence-Tumor Prevention and Treatment, Guangxi Medical University, Nanning, China – sequence: 9 givenname: Kazuhiko surname: Takeuchi fullname: Takeuchi, Kazuhiko email: kazuhiko@med.mie-u.ac.jp organization: Department of Otolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan – sequence: 10 givenname: Mariko orcidid: 0000-0003-3668-7214 surname: Murata fullname: Murata, Mariko email: mmurata@med.mie-u.ac.jp organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34922336$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9u1DAUxi1URKeFLUvkJSzS8b94kiUUpq1UwQJYR8-OMzFK7GB7VM2ud-gRuAFLDtFDcBLcycACCSE_yQv_vvf8vu8EHTnvDELPKTmjpOZLDUFbt1QbUJSxR2hBhSQFoxU5QgtCBS845-IYncT4hRAqeVk_Qcdc1IxxLhfo28XbNSXYut4qmyLWZhjwFPxgOxMgWe8wuBabyabeDBaGn7d3o4nG6X43woBTABftnrMOO4h-6iHs3Mbkx_lzfgSsdjjrZ7rzYbRugzfB36Qed6CTD8X99-XHEdr9tPfr4v7HGzxB6m9gF5-ixx0M0Tw73Kfo8_rdp_PL4vrDxdX56-tCc1anQlZdp0WlQArGDa9WsuxqsgIhhdatElJTVcp8KqW6XK2pqCDVivGa81ZQfopezn3z_l-3JqZmtPHBEHDGb2PDJKWy5CtSZvTFAd2q0bTNFOyY125-G5uBsxnQwccYTPcHoaR5SK6ZzWkOyWWB-EugbdoHkE2zw79lr2aZ307_G_ELXbOzqw |
CitedBy_id | crossref_primary_10_1155_2022_7117083 crossref_primary_10_3892_ol_2023_13977 crossref_primary_10_1002_hed_27569 crossref_primary_10_1186_s40001_024_01932_2 crossref_primary_10_1093_carcin_bgae054 crossref_primary_10_1016_j_omton_2024_200858 crossref_primary_10_1016_j_xgen_2023_100411 |
Cites_doi | 10.1016/j.yexcr.2018.11.021 10.1593/neo.05625 10.1016/j.radonc.2019.04.025 10.1186/s13046-017-0554-9 10.12688/f1000research.18872.1 10.1158/1535-7163.MCT-15-0260 10.1016/j.imlet.2019.01.007 10.1073/pnas.1103441108 10.1002/mc.22297 10.3389/fcell.2020.00417 10.1016/j.canlet.2013.05.018 10.18632/aging.101983 10.1038/sj.onc.1207441 10.1016/S1044579X02000883 10.1002/cam4.451 10.3892/ol.2014.2322 10.5487/TR.2010.26.4.245 10.1158/0008-5472.CAN-17-1051 10.1038/onc.2012.171 10.18632/oncotarget.23826 10.1101/cshperspect.a022137 10.1158/1541-7786.MCR-17-0134 10.1007/s00726-018-2651-2 10.1093/jjco/hyg092 10.4103/0976-500X.119726 10.7150/ijbs.7.1056 10.1158/1055-9965.EPI-06-0353 10.1016/j.radonc.2013.10.020 10.1038/sj.neo.7900162 10.2147/DDDT.S199182 10.1002/ijc.25173 |
ContentType | Journal Article |
Copyright | The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2021 The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2021 – notice: The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1093/carcin/bgab122 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2180 |
EndPage | 103 |
ExternalDocumentID | 34922336 10_1093_carcin_bgab122 10.1093/carcin/bgab122 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Japan Society for the Promotion of Science grantid: JP16H05829 |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .ZR 0R~ 18M 1TH 29B 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 6J9 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABDFA ABEFU ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABMNT ABNGD ABNHQ ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABVGC ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACMRT ACNCT ACPQN ACPRK ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AHMBA AHMMS AHXPO AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD ELUNK EMOBN F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RHF RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H X7M XOL YAYTL YKOAZ YXANX ZGI ZKB ZKX ZXP ~91 AAYXX ABPQP ABXZS ADNBA AGORE AHGBF AJBYB AJNCP ALXQX CITATION JXSIZ CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c329t-68ffc48ba6423e38765f907a464ccdb46c1b565658bbfbbfde81408723933d413 |
ISSN | 0143-3334 1460-2180 |
IngestDate | Thu Jul 10 18:40:27 EDT 2025 Thu Apr 03 06:57:54 EDT 2025 Thu Apr 24 22:56:58 EDT 2025 Tue Jul 01 04:21:35 EDT 2025 Tue Feb 11 07:50:34 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c329t-68ffc48ba6423e38765f907a464ccdb46c1b565658bbfbbfde81408723933d413 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3668-7214 0000-0002-7376-5691 |
PMID | 34922336 |
PQID | 2611653705 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2611653705 pubmed_primary_34922336 crossref_primary_10_1093_carcin_bgab122 crossref_citationtrail_10_1093_carcin_bgab122 oup_primary_10_1093_carcin_bgab122 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-24 |
PublicationDateYYYYMMDD | 2022-03-24 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-24 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | UK |
PublicationPlace_xml | – name: UK – name: England |
PublicationTitle | Carcinogenesis (New York) |
PublicationTitleAlternate | Carcinogenesis |
PublicationYear | 2022 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Dai (2022032516110725200_CIT0007) 2004; 23 Zhou (2022032516110725200_CIT0010) 2019; 11 Lan (2022032516110725200_CIT0035) 2011; 7 Suwannakul (2022032516110725200_CIT0022) 2020; 8 Liang (2022032516110725200_CIT0025) 2019; 13 Dai (2022032516110725200_CIT0029) 2001; 3 Yamashita (2022032516110725200_CIT0034) 2019; 207 Gilmore (2022032516110725200_CIT0030) 2019; 8 Son (2022032516110725200_CIT0032) 2010; 26 Sun (2022032516110725200_CIT0004) 2014; 110 Dai (2022032516110725200_CIT0013) 2015; 4 Zhang (2022032516110725200_CIT0015) 2017; 15 Yu-Lee (2022032516110725200_CIT0006) 2018; 78 Huang (2022032516110725200_CIT0031) 2019; 374 Zhao (2022032516110725200_CIT0020) 2017; 36 Gos (2022032516110725200_CIT0024) 2009; 55 Luo (2022032516110725200_CIT0012) 2017; 9 Lo (2022032516110725200_CIT0028) 2002; 12 Jiang (2022032516110725200_CIT0014) 2015; 14 Li (2022032516110725200_CIT0011) 2017; 38 Chang (2022032516110725200_CIT0001) 2006; 15 Kimura (2022032516110725200_CIT0008) 2008; 20 He (2022032516110725200_CIT0019) 2018; 50 Xue (2022032516110725200_CIT0026) 2018; 15 Yoshizaki (2022032516110725200_CIT0023) 2013; 337 Tsang (2022032516110725200_CIT0017) 2010; 127 Charan (2022032516110725200_CIT0021) 2013; 4 Park (2022032516110725200_CIT0009) 2014; 8 Lo (2022032516110725200_CIT0016) 2006; 8 Upadhyay (2022032516110725200_CIT0027) 2011; 108 Yao (2022032516110725200_CIT0002) 2019; 137 Freudlsperger (2022032516110725200_CIT0033) 2013; 32 Hou (2022032516110725200_CIT0018) 2018; 9 Liu (2022032516110725200_CIT0003) 2003; 33 Cheng (2022032516110725200_CIT0005) 2016; 55 |
References_xml | – volume: 374 start-page: 172 year: 2019 ident: 2022032516110725200_CIT0031 article-title: Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway publication-title: Exp. Cell Res., doi: 10.1016/j.yexcr.2018.11.021 – volume: 8 start-page: 173 year: 2006 ident: 2022032516110725200_CIT0016 article-title: Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells publication-title: Neoplasia, doi: 10.1593/neo.05625 – volume: 137 start-page: 137 year: 2019 ident: 2022032516110725200_CIT0002 article-title: Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis publication-title: Radiother. Oncol., doi: 10.1016/j.radonc.2019.04.025 – volume: 36 start-page: 88 year: 2017 ident: 2022032516110725200_CIT0020 article-title: RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma publication-title: J. Exp. Clin. Cancer Res., doi: 10.1186/s13046-017-0554-9 – volume: 8 start-page: 1793 year: 2019 ident: 2022032516110725200_CIT0030 article-title: Emerging approaches to target mitochondrial apoptosis in cancer cells publication-title: F1000Res doi: 10.12688/f1000research.18872.1 – volume: 14 start-page: 2864 year: 2015 ident: 2022032516110725200_CIT0014 article-title: Genome-wide identification of a methylation gene panel as a prognostic biomarker in nasopharyngeal carcinoma publication-title: Mol. Cancer Ther., doi: 10.1158/1535-7163.MCT-15-0260 – volume: 38 start-page: 206 year: 2017 ident: 2022032516110725200_CIT0011 article-title: Rediscovery of the sun bear (Helarctos malayanus) in Yingjiang County, Yunnan Province, China publication-title: Zool. Res., – volume: 207 start-page: 64 year: 2019 ident: 2022032516110725200_CIT0034 article-title: Genetic variants of SMAD2/3/4/7 are associated with susceptibility to ulcerative colitis in a Japanese genetic background publication-title: Immunol. Lett., doi: 10.1016/j.imlet.2019.01.007 – volume: 108 start-page: 7820 year: 2011 ident: 2022032516110725200_CIT0027 article-title: Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling publication-title: Proc. Natl. Acad. Sci. USA, doi: 10.1073/pnas.1103441108 – volume: 55 start-page: 499 year: 2016 ident: 2022032516110725200_CIT0005 article-title: Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma publication-title: Mol. Carcinog., doi: 10.1002/mc.22297 – volume: 20 start-page: 1265 year: 2008 ident: 2022032516110725200_CIT0008 article-title: The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas publication-title: Oncol. Rep., – volume: 8 start-page: 417 year: 2020 ident: 2022032516110725200_CIT0022 article-title: CD44v9 induces stem cell-like phenotypes in human cholangiocarcinoma publication-title: Front. Cell Dev. Biol., doi: 10.3389/fcell.2020.00417 – volume: 337 start-page: 1 year: 2013 ident: 2022032516110725200_CIT0023 article-title: Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma publication-title: Cancer Lett., doi: 10.1016/j.canlet.2013.05.018 – volume: 11 start-page: 3298 year: 2019 ident: 2022032516110725200_CIT0010 article-title: GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7 publication-title: Aging (Albany. NY)., doi: 10.18632/aging.101983 – volume: 23 start-page: 3521 year: 2004 ident: 2022032516110725200_CIT0007 article-title: Bone morphogenetic protein 3B silencing in non-small-cell lung cancer publication-title: Oncogene, doi: 10.1038/sj.onc.1207441 – volume: 12 start-page: 451 year: 2002 ident: 2022032516110725200_CIT0028 article-title: Genetic and epigenetic changes in nasopharyngeal carcinoma publication-title: Semin. Cancer Biol., doi: 10.1016/S1044579X02000883 – volume: 4 start-page: 1079 year: 2015 ident: 2022032516110725200_CIT0013 article-title: Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma publication-title: Cancer Med., doi: 10.1002/cam4.451 – volume: 8 start-page: 1613 year: 2014 ident: 2022032516110725200_CIT0009 article-title: Microarray-based DNA methylation study of Ewing’s sarcoma of the bone publication-title: Oncol. Lett., doi: 10.3892/ol.2014.2322 – volume: 26 start-page: 245 year: 2010 ident: 2022032516110725200_CIT0032 article-title: Epithelial-mesenchymal transition and cell invasion publication-title: Toxicol. Res., doi: 10.5487/TR.2010.26.4.245 – volume: 78 start-page: 2911 year: 2018 ident: 2022032516110725200_CIT0006 article-title: Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFβRIII-p38MAPK-pS249/T252RB pathway publication-title: Cancer Res., doi: 10.1158/0008-5472.CAN-17-1051 – volume: 32 start-page: 1549 year: 2013 ident: 2022032516110725200_CIT0033 article-title: TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers publication-title: Oncogene, doi: 10.1038/onc.2012.171 – volume: 9 start-page: 8927 year: 2018 ident: 2022032516110725200_CIT0018 article-title: Let-7c inhibits migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2 publication-title: Oncotarget, doi: 10.18632/oncotarget.23826 – volume: 9 year: 2017 ident: 2022032516110725200_CIT0012 article-title: Signaling cross talk between TGF-beta/Smad and other signaling pathways publication-title: Cold Spring Harb. Perspect. Biol., doi: 10.1101/cshperspect.a022137 – volume: 15 start-page: 1722 year: 2017 ident: 2022032516110725200_CIT0015 article-title: Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes publication-title: Mol. Cancer Res., doi: 10.1158/1541-7786.MCR-17-0134 – volume: 50 start-page: 1749 year: 2018 ident: 2022032516110725200_CIT0019 article-title: Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro publication-title: Amino Acids, doi: 10.1007/s00726-018-2651-2 – volume: 33 start-page: 501 year: 2003 ident: 2022032516110725200_CIT0003 article-title: Prognostic factors affecting the outcome of nasopharyngeal carcinoma publication-title: Jpn. J. Clin. Oncol., doi: 10.1093/jjco/hyg092 – volume: 4 start-page: 303 year: 2013 ident: 2022032516110725200_CIT0021 article-title: How to calculate sample size in animal studies? publication-title: J. Pharmacol. Pharmacother., doi: 10.4103/0976-500X.119726 – volume: 7 start-page: 1056 year: 2011 ident: 2022032516110725200_CIT0035 article-title: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation publication-title: Int. J. Biol. Sci., doi: 10.7150/ijbs.7.1056 – volume: 15 start-page: 1765 year: 2006 ident: 2022032516110725200_CIT0001 article-title: The enigmatic epidemiology of nasopharyngeal carcinoma publication-title: Cancer Epidemiol. Biomarkers Prev., doi: 10.1158/1055-9965.EPI-06-0353 – volume: 110 start-page: 398 year: 2014 ident: 2022032516110725200_CIT0004 article-title: Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities publication-title: Radiother. Oncol., doi: 10.1016/j.radonc.2013.10.020 – volume: 15 start-page: 7693 year: 2018 ident: 2022032516110725200_CIT0026 article-title: Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-κB publication-title: Oncol. Lett., – volume: 55 start-page: 121 year: 2009 ident: 2022032516110725200_CIT0024 article-title: [Epithelial-mesenchymal transition in cancer progression] publication-title: Postepy Biochem., – volume: 3 start-page: 314 year: 2001 ident: 2022032516110725200_CIT0029 article-title: Global methylation profiling of lung cancer identifies novel methylated genes publication-title: Neoplasia, doi: 10.1038/sj.neo.7900162 – volume: 13 start-page: 1335 year: 2019 ident: 2022032516110725200_CIT0025 article-title: Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway publication-title: Drug Des. Dev. Ther., doi: 10.2147/DDDT.S199182 – volume: 127 start-page: 1570 year: 2010 ident: 2022032516110725200_CIT0017 article-title: Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization publication-title: Int. J. Cancer, doi: 10.1002/ijc.25173 |
SSID | ssj0016359 |
Score | 2.4296887 |
Snippet | Abstract
Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway... Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 94 |
SubjectTerms | Cell Line, Tumor Cell Movement - genetics Cell Proliferation - genetics Epithelial-Mesenchymal Transition - genetics Gene Expression Regulation, Neoplastic Growth Differentiation Factor 10 - genetics Humans Nasopharyngeal Carcinoma - genetics Nasopharyngeal Neoplasms - genetics NF-kappa B - genetics NF-kappa B - metabolism Transforming Growth Factor beta - genetics Transforming Growth Factor beta - metabolism |
Title | GDF10 inhibits cell proliferation and epithelial–mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34922336 https://www.proquest.com/docview/2611653705 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKICE2iDflJYMYsRiFpnHqpstp51FAnQ0z0uwqO3HaiDYZtalGZcU_8An8AUs-Yj6CFZ_BvbHzYqgYkKooihzncU_sc2_vPSbkFRcOB9rBLL8rbMttKxe-OcGtjhd0ZSCECCUWOI-O-PDEfXfaOW00flayllapfON_-mNdyf9YFY6BXbFK9h8sW3QKB2Af7AtbsDBsr2Tjwz3wh3eieBpJjP9jEB4TrmaYrqINi2FxdYZ1FzO4nTyzgc2x5sifrudZqjnMVlGe8xgLXNdALNbxBCWHfVxqKE7mIqOpAKk0J7oYYpiAD59OzZo91vZgf7uPQqsf5iITgN05OtAHd_uo3zo9F-tllQwPdOcTHG6jZX1doCI-MdT5x8rMsBlr1ePT4SoJVVSG1DWwy3ajKEgW0UdxbqreksWqGuMA99hmllPGODfUTtbCosxizIRFlR7KXW5bQGDs6livJaEMpp3KwN1zKxSgnckuXJ5dtPKWfvOwIydCtnVV9W-a3ZsbXyPXHXBocK2Nvbfvi_-7gPb1dLKtfo5CXpS1dA8tc36NPtVKMi95RhlDOr5NbhnXhu5qnN4hDRXfJTdGJnnjHvmawZXmcKUIV1qDKwXQ0BKuPz5_qQCVlkCFPmgdqLQAKpVrCufTKlCpBio1QL341kKIZlcDiF5879McnvfJycH-8WBomTVCLJ85vdTiXhj6ricF-NFMMZjbO2HP7gqXu74fSJf7bYk-S8eTMoRfoFDizeui8h8LgME9IFtxEqtHhDLJw6AdcqBvgYv5CMB8Q9_2XJ_3HMWCJrHyVz_2jYA-ruMyG-tEDjbWjzo2pmqS10X7My0ds7HlS7DkXxu9yA09hikAbSRilayWY4ejhhbr2p0meagRUPSF4qMOY_zxVS7xhNwsv76nZCtdrNQz4NypfJ7B9Rf25ODP |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GDF10+inhibits+cell+proliferation+and+epithelial%E2%80%93mesenchymal+transition+in+nasopharyngeal+carcinoma+by+the+transforming+growth+factor-%CE%B2%2FSmad+and+NF-%CE%BAB+pathways&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=He%2C+Feng&rft.au=Feng%2C+Guofei&rft.au=Ma%2C+Ning&rft.au=Midorikawa%2C+Kaoru&rft.date=2022-03-24&rft.pub=Oxford+University+Press&rft.issn=0143-3334&rft.eissn=1460-2180&rft.volume=43&rft.issue=2&rft.spage=94&rft.epage=103&rft_id=info:doi/10.1093%2Fcarcin%2Fbgab122&rft.externalDocID=10.1093%2Fcarcin%2Fbgab122 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon |